2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Leiomyoma
19
Myofibroma
4
Menorrhagia
4
Myoma
3
Infertility
3
Adenomyosis
2
Sexual Dysfunction, Physiological
1
Pregnancy Complications
1
Polyps
1
Pelvic Pain
1
Lower Urinary Tract Symptoms
1
Hemorrhage
1
Fibroma
1
Endometriosis
1
Dysmenorrhea
1
Blood Loss, Surgical
1
Agnosia
1
Interventions
Misoprostol
4
Tranexamic Acid
3
Saline Solution
2
Aprotinin
2
maleimide-polyethylene glycol-modified hemoglobin, MP4
1
carbetocin
1
Vasopressins
1
Uterine Myomectomy
1
Tranylcypromine
1
Tourniquets
1
Tidal Volume
1
Terlipressin
1
Tablets
1
Sodium Chloride
1
Ringer's Solution
1
Ringer's Lactate
1
Population Groups
1
Oxytocin
1
Neuromuscular Blockade
1
Ethamsylate
1
Embolization, Therapeutic
1
Cerebral Angiography
1
Bupivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Blood Loss, Surgical
×
Uterine Myomectomy
×
Clear all
NCT06882824
2025-09-24
HEMOMYOC
University Hospital, Clermont-Ferrand
Phase NA
Recruiting
80 enrolled